Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. (BOLT) — Form SCHEDULE 13G: Ownership over 5% (passive)

SC 13GBOLTFiled Nov 6, 2026, 1:05 PM ET

About this filing

Bolt Biotherapeutics, Inc. (BOLT) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Nov 6, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

View original filing on SEC.gov

Key facts

Document: —

More BOLT filings

4
Insider transaction
Filed Nov 10, 2026
3
Initial insider holdings
Filed Nov 6, 2026
4
Insider transaction
Filed Oct 27, 2026
3
Initial insider holdings
Filed Oct 27, 2026
8-K
Current report
Filed Oct 23, 2026
8-K
Current report
Filed Oct 6, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.